
|Podcasts|July 7, 2021
Getting Clinical Trials, Cancer Screenings Back on Track with Tech to Avoid Wave of Patients Post-COVID
Author(s)Briana Contreras
MHE Associate Editor, Briana Contreras, spoke with CEO of Inteliquet, a cancer solutions provider that strives to match patients to clinical trials accurately and promptly in healthcare, Marie Lamont. In this episode Marie discusses the challenges that have affected clinical trials and cancer screenings and how to get trials back on track through technology to avoid the wave of undiagnosed patients post-COVID. She also shared how broadening them through diversity can improve trials.
Advertisement
To listen to more episodes featured on Tuning Into The C-Suite, visit us on
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
What NCCN’s next CMO sees ahead for cancer guidelines, access and innovation
2
Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis
3
5 developments in the treatment of prurgio nodularis in 2025
4
Top 5 stories from Formulary Watch in 2025
5





















































